Zimmer Biomet Holdings Q4 Adjusted EPS $2.20 Beats $2.15 Estimate, Sales $1.94B Beat $1.93B Estimate
Portfolio Pulse from Benzinga Newsdesk
Zimmer Biomet Holdings (ZBH) reported Q4 earnings of $2.20 per share, surpassing the $2.15 estimate, marking a 17.02% increase from last year. Sales reached $1.94B, exceeding the $1.93B estimate, a 6.31% increase from the previous year.
February 08, 2024 | 11:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zimmer Biomet Holdings reported a significant beat on both earnings and sales estimates for Q4, with a notable year-over-year growth.
Beating both earnings and sales estimates indicates strong financial health and operational efficiency, which is likely to instill investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100